|
|
||||||||
Ann Thorac Surg 2007;84:1301-1311
© 2007 The Society of Thoracic Surgeons
a Herma Heart Center and Childrens Research Institute, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin
b Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
c Department of Surgery, The Section of Critical Care, Medical College of Wisconsin, Milwaukee, Wisconsin
d Department of Cardiology, Medical College of Wisconsin, Milwaukee, Wisconsin
e Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin
f Department of Anesthesia, Medical College of Wisconsin, Milwaukee, Wisconsin
Accepted for publication May 1, 2007.
* Address correspondence to Dr Tweddell, Childrens Hospital of Wisconsin, 9000 W. Wisconsin Ave, Milwaukee, WI 53226 (Email: jtweddell{at}chw.org).
Presented at the Forty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 29–31, 2007.
Background: Staged palliation for hypoplastic left heart syndrome has been marked by high early mortality due to the limited cardiac output of the postischemic single right ventricle combined with the inefficiency and volatility of parallel circulation.
Methods: Since July 1996, we have performed stage 1 palliation (S1P) in 178 patients. Within this group is a consecutive cohort of 116 patients with true hypoplastic left heart syndrome that underwent S1P with a modified Blalock-Taussig shunt. A prospective database containing postoperative hemodynamic data was maintained on all patients. Studied were the incidence of organ failure, extracorporeal membrane oxygenation (ECMO), and mortality, as well as the relationship between these outcomes and postoperative hemodynamics.
Results: Hospital survival for this cohort was 93% (108/116). Patients who died after S1P had a lower superior vena cava oxygen saturation (SvO 2) level compared with survivors (53.1% ±10.6% versus 59.3% ±9.2%, p = 0.034). Renal failure developed in 2 (1.7%) of the 116 patients, necrotizing enterocolitis developed in 1 (0.9%), and 5 (4.3%) had clinical seizures. ECMO support was instituted in 12 patients (10.3%). The SvO 2 level was lower in patients requiring ECMO (54.0% ± 9.7% versus 59.9% ± 9.2%, p = 0.031).
Conclusions: Goal-directed therapy with SvO 2 as an indicator of systemic oxygen delivery is associated with excellent early survival and a low incidence of organ failure after S1P. Inability to optimize SvO 2 in the early postoperative period is associated with an increased risk of organ failure, ECMO, and death.
This article has been cited by other articles:
![]() |
H. M. Phelps, W. T. Mahle, D. Kim, J. M. Simsic, P. M. Kirshbom, K. R. Kanter, and K. O. Maher Postoperative cerebral oxygenation in hypoplastic left heart syndrome after the Norwood procedure. Ann. Thorac. Surg., May 1, 2009; 87(5): 1490 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Johnson, G. M. Hoffman, J. S. Tweddell, J. R. Cava, M. Basir, M. E. Mitchell, M. C. Scanlon, K. A. Mussatto, and N. S. Ghanayem Near-infrared spectroscopy in neonates before palliation of hypoplastic left heart syndrome. Ann. Thorac. Surg., February 1, 2009; 87(2): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |